PL2001469T3 - Analogi tiazolidynodionu - Google Patents

Analogi tiazolidynodionu

Info

Publication number
PL2001469T3
PL2001469T3 PL07753040T PL07753040T PL2001469T3 PL 2001469 T3 PL2001469 T3 PL 2001469T3 PL 07753040 T PL07753040 T PL 07753040T PL 07753040 T PL07753040 T PL 07753040T PL 2001469 T3 PL2001469 T3 PL 2001469T3
Authority
PL
Poland
Prior art keywords
thiazolidinedione analogues
thiazolidinedione
analogues
Prior art date
Application number
PL07753040T
Other languages
English (en)
Inventor
Gerard R Colca
Rolf F Kletzien
Original Assignee
Metabolic Solutions Dev Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Solutions Dev Co Llc filed Critical Metabolic Solutions Dev Co Llc
Publication of PL2001469T3 publication Critical patent/PL2001469T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07753040T 2006-03-16 2007-03-14 Analogi tiazolidynodionu PL2001469T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78278706P 2006-03-16 2006-03-16
PCT/US2007/006385 WO2007109037A2 (en) 2006-03-16 2007-03-14 Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
EP07753040A EP2001469B1 (en) 2006-03-16 2007-03-14 Thiazolidinedione analogues

Publications (1)

Publication Number Publication Date
PL2001469T3 true PL2001469T3 (pl) 2012-10-31

Family

ID=38433001

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07753040T PL2001469T3 (pl) 2006-03-16 2007-03-14 Analogi tiazolidynodionu

Country Status (11)

Country Link
US (1) US8629159B2 (pl)
EP (1) EP2001469B1 (pl)
JP (2) JP5149271B2 (pl)
CN (1) CN101454006B (pl)
AU (1) AU2007227594B2 (pl)
CA (1) CA2646149A1 (pl)
ES (1) ES2388555T3 (pl)
MX (1) MX2008011872A (pl)
NZ (1) NZ571870A (pl)
PL (1) PL2001469T3 (pl)
WO (1) WO2007109037A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2001470A2 (en) * 2006-03-16 2008-12-17 Metabolic Solutions Development Company Combination therapies of thiazolidinedione analogues
MX356584B (es) 2006-03-16 2018-06-05 Metabolic Solutions Dev Co Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
PL2001469T3 (pl) 2006-03-16 2012-10-31 Metabolic Solutions Dev Co Llc Analogi tiazolidynodionu
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ597381A (en) * 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
DK2513070T3 (en) 2009-12-15 2018-01-22 Cirius Therapeutics Inc PPAR-sparing thiazolidinedione salts for the treatment of metabolic disorders
MX2012006730A (es) * 2009-12-15 2012-07-30 Metabolic Solutions Dev Co Llc Tiazolidinadionas moderadoras de receptores activados por proliferador de peroxizoma (ppar) y combinaciones para tratamiento de enfermedades neurodegenerativas y otras enfermedades metabolicas.
WO2011133441A2 (en) * 2010-04-19 2011-10-27 Metabolic Solutions Development Company Novel synthesis for thiazolidinedione compounds
WO2011133442A1 (en) * 2010-04-19 2011-10-27 Metabolic Solutions Development Company Novel synthesis for thiazolidinedione compounds
WO2012021476A1 (en) 2010-08-10 2012-02-16 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
CN102370984B (zh) * 2010-08-18 2015-04-08 天津金耀集团有限公司 以依普利酮和糖皮质激素为活性成分的吸入药物组合物
ES2813363T3 (es) 2013-07-22 2021-03-23 Metabolic Solutions Dev Co Llc Compuestos ahorradores de PPAR para el tratamiento de enfermedades metabólicas
US12521380B2 (en) 2017-01-25 2026-01-13 The George Institute for Global Health Compositions for the treatment of hypertension
PT3573620T (pt) 2017-01-25 2023-03-20 The George Inst For Global Health Composições para o tratamento da hipertensão
GB202210503D0 (en) 2022-07-18 2022-08-31 Univ Court Univ Of Glasgow Materials and methods for treatment of chronic myeloid leukemia (CML)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
WO1985004170A1 (fr) * 1984-03-21 1985-09-26 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, leur procede de preparation et compositions medicinales les contenant
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
WO1986002073A1 (fr) 1984-10-03 1986-04-10 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, procede de preparation et composition pharmaceutique les contenant
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US5167228A (en) * 1987-06-26 1992-12-01 Brigham And Women's Hospital Assessment and modification of endogenous circadian phase and amplitude
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5356913A (en) * 1990-02-09 1994-10-18 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
SK109993A3 (en) * 1991-04-11 1994-12-07 Upjohn Co Thiazolidinedione derivatives producing and use thereof
US5441971A (en) * 1991-04-11 1995-08-15 The Upjohn Company Thiazolidinedione derivatives, production and use thereof
NO302471B1 (no) 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
IL118778A (en) * 1995-07-03 1999-07-14 Sankyo Co Pharmaceutical compositions for the treatment of arteriosclerosis and xanthoma containing an hmg-coa reductase inhibitor
EP1353727A2 (en) * 2000-12-01 2003-10-22 Novartis AG Combinations of an angiotensin receptor antagonist and an anti-hypertensive drugor a statin, for the treatment of sexual dysfunction
HUP0400091A2 (hu) 2001-04-26 2004-06-28 Léciva, a.s. Eljárás antidiabetikus hatású pioglitazon előállítására
AUPS236902A0 (en) * 2002-05-16 2002-06-13 Northern Sydney Area Health Service Composition and method for treating hypertension
ITFI20030058A1 (it) 2003-03-06 2004-09-07 Univ Firenze Formulazioni farmaceutiche contenenti tiazolidinedioni
MX356584B (es) * 2006-03-16 2018-06-05 Metabolic Solutions Dev Co Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
PL2001469T3 (pl) 2006-03-16 2012-10-31 Metabolic Solutions Dev Co Llc Analogi tiazolidynodionu
EP2001470A2 (en) 2006-03-16 2008-12-17 Metabolic Solutions Development Company Combination therapies of thiazolidinedione analogues
NZ597381A (en) 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases

Also Published As

Publication number Publication date
MX2008011872A (es) 2009-02-10
CN101454006A (zh) 2009-06-10
AU2007227594B2 (en) 2012-11-15
US20090137638A1 (en) 2009-05-28
ES2388555T3 (es) 2012-10-16
WO2007109037A3 (en) 2007-11-08
EP2001469B1 (en) 2012-05-23
NZ571870A (en) 2011-07-29
US8629159B2 (en) 2014-01-14
CA2646149A1 (en) 2007-09-27
JP2012251001A (ja) 2012-12-20
WO2007109037A2 (en) 2007-09-27
JP2009530286A (ja) 2009-08-27
AU2007227594A1 (en) 2007-09-27
JP5149271B2 (ja) 2013-02-20
EP2001469A2 (en) 2008-12-17
CN101454006B (zh) 2012-12-26

Similar Documents

Publication Publication Date Title
PL2001468T3 (pl) Analogi tiazolidynodionu
PL2001469T3 (pl) Analogi tiazolidynodionu
DE602007002700D1 (en) Interventionsfreies frac-system
DE602007014031D1 (en) Luftreifensatz
PL1849352T3 (pl) Kombajn
DE602007003855D1 (en) Isothermer reaktor
IL180020A0 (en) Encryption -and decryption-enabled interfaces
DE602007006989D1 (en) Spiropiperidinderivate
EP2084019A4 (en) PAINT SCRAPER
EP2007388A4 (en) OPIOPATHIEN
IL194493A0 (en) Thiazolyl dihydro-indazoles
ZA200708752B (en) Component
EP1974618A4 (en) UNDERWEAR
GB2474382B8 (en) Construction component
DE502007001126D1 (en) Eiten
GB0610713D0 (en) Flexi-garden-design
GB0609741D0 (en) Cybertree
AU4914P (en) CalflatGL Calothamnus quadrifidus
AU3514P (en) ARCBENT Arctotis fastuosa
GB0617866D0 (en) Jarjar (jaropener)
GB0611471D0 (en) Interface
GB0609691D0 (en) Corcost 5a
GB0607054D0 (en) Ehur
GB0604989D0 (en) Evruc-1
GB0609846D0 (en) Tmter